Lowering Medical Costs Through the Sharing of Savings by Physicians and Patients
- 1 December 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 174 (12), 2009-2013
- https://doi.org/10.1001/jamainternmed.2014.5367
Abstract
Current approaches to controlling health care costs have strengths and weaknesses. We propose an alternative, “inclusive shared savings,” that aims to lower medical costs through savings that are shared by physicians and patients. Inclusive shared savings may be particularly attractive in situations in which treatments, such as those for gastric cancer, are similar in clinical effectiveness and have modest differences in convenience but substantially differ in cost. Inclusive shared savings incorporates features of typical insurance coverage, shared savings, and value-based insurance design but differs from value-based insurance design, which merely seeks to decrease or eliminate out-of-pocket costs. Inclusive shared savings offers financial incentives to physicians and patients to promote the use of lower-cost, but equally effective, interventions and should be evaluated in a rigorous trial or demonstration project.Keywords
This publication has 9 references indexed in Scilit:
- Controlling Costs by Expanding the Medicare Acute Care Episode DemonstrationJAMA Internal Medicine, 2014
- Focus Groups Highlight That Many Patients Object To Clinicians’ Focusing On CostsHealth Affairs, 2013
- Managing the financial impact of cancer treatment: the role of clinical practice guidelines.Journal of the National Comprehensive Cancer Network, 2012
- Value-based insurance design in oncologyThe Lancet Oncology, 2011
- Evidence That Consumers Are Skeptical About Evidence-Based Health CareHealth Affairs, 2010
- Informative inducement: Study payment as a signal of riskSocial Science & Medicine, 2009
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerNew England Journal of Medicine, 2008
- Empirical Assessment of Whether Moderate Payments Are Undue or Unjust Inducements for Participation in Clinical TrialsArchives of Internal Medicine, 2004
- Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?Health Affairs, 2003